Reaching the 2030 HIV incidence goals in high burden settings, particularly in East and Southern Africa, and then keeping HIV incidence at low levels will require the right combination of effective prevention interventions at high coverage levels.



In 2007 the United Nations Joint Programme on HIV/AIDS (UNAIDS) and the World Health Organization (WHO) recommended VMMC to reduce the risk of men acquiring HIV infection during heterosexual exposure. The recommendation was based on strong evidence from randomized controlled trials of an approximately 60% lower risk.